![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | |
A61P 25/04 |
(11) | Number of the document | 2125019 |
(13) | Kind of document | T |
(96) | European patent application number | 08709412.4 |
Date of filing the European patent application | 2008-02-15 | |
(97) | Date of publication of the European application | 2009-12-02 |
(45) | Date of publication and mention of the grant of the patent | 2014-04-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2008/000521 |
Date | 2008-02-15 |
(87) | Number | WO 2008/104735 |
Date | 2008-09-04 |
(30) | Number | Date | Country code |
0703966 | 2007-03-01 | GB |
(72) |
CHAPLEO, Christopher, Bourne, GB
HYDE, Neil, GB
|
(73) |
RB Pharmaceuticals Limited,
103-105 Bath Road Slough, Berkshire SL1 3UH,
GB
|
(54) | IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE |
IMPROVED MEDICINAL COMPOSITIONS COMPRISING BUPRENORPHINE AND NALTREXONE |